Sleep Apnea Linked to Morning Hypertension, Study Finds
Research highlights a significant association between obstructive sleep apnea (OSA) and morning hypertension, emphasizing the importance of screening for sleep disorders in patients with elevated blood pressure. According to the study, a significant number of participants with OSA exhibited sustained morning hypertension, compared to those without the condition.
Why Is Sleep Apnea Connected to High Blood Pressure?
Obstructive sleep apnea, characterized by repeated pauses in breathing during sleep, disrupts normal oxygen levels and triggers stress responses in the body. “These episodes activate the sympathetic nervous system, leading to increased heart rate and vascular resistance,” explained a sleep medicine specialist. “This physiological stress can persist into the morning, causing elevated blood pressure.”
How Common Is This Link?
A meta-analysis reviewed data from studies involving participants. The findings revealed that individuals with untreated OSA were more likely to develop morning hypertension than those without the disorder. “This underscores the need for early diagnosis and intervention,” said a cardiovascular researcher.
What Should Patients Do?
Health organizations recommend that adults with unexplained high blood pressure undergo sleep studies. “Even mild sleep apnea can contribute to cardiovascular risks,” noted a pulmonologist. “Continuous positive airway pressure (CPAP) therapy has been shown to reduce morning hypertension in many cases.”
Key Takeaways
- Obstructive sleep apnea is linked to morning hypertension in a significant number of cases, per recent research.
- Disrupted oxygen levels during sleep trigger stress responses that elevate blood pressure.
- CPAP therapy can significantly lower morning hypertension in patients with OSA.
- Healthcare providers should prioritize sleep disorder screening for patients with persistent high blood pressure.
What’s Next for Research?
Future studies aim to explore how prolonged use affects cardiovascular outcomes. A trial will track OSA patients over time to assess whether treating sleep apnea reduces heart attack or stroke risk.